This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • World Health  • Statistics and Research Methods  • Malaria  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Gianna Zuccotti, MD, MPH; Catherine D. DeAngelis, MD, MPH

JAMA. 2007;297(20):2285-2286.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Malaria remains a leading cause of morbidity and mortality globally. An estimated 3 billion individuals live in areas of risk and the disease causes more than 1 million deaths annually.¹ Even in the United States, where endemic malaria has been eradicated for decades, an average of 1200 cases are reported annually.² The articles in this issue of JAMA on malaria address a number of important issues, including the financial and logistic challenges of implementing new technologies for disease prevention and diagnosis; improvement in understanding risk factors and disease severity, particularly in children; and treatment and surveillance approaches in the face of evolving drug resistance.

The diagnosis and management of malaria in endemic areas have tremendous financial impact. As Feachem and Sabot³ outline in their Commentary in this issue of JAMA, there is currently a resurgence of interest in the burden . . . [Full Text of this Article]

Author Affiliations: Dr Zuccotti (zuccottg@mskcc.org) is Contributing Editor and Dr DeAngelis is Editor in Chief, JAMA.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epidemiology of Acute Kidney Injury
Cerda et al.
CJASN 2008;3:881-886.
ABSTRACT | FULL TEXT